Categories
Tags
Authors: Duarte M, Pelorosso F, Nicolosi L, Salgado V, Vetulli H PMID: 34189447 PMCID: PMC8225700 DOI: 10.1016/j.eclinm.2021.100962 Abstract Background: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. Methods: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patients from 18 [...]
Categories: I-CARE Early Covid, MATH+
Tags: COVID-19, telmisartan
Authors: Rothlin RP, Vetulli HM, Duarte M, Pelorosso FG PMID: 32356926 PMCID: PMC7267340 DOI: 10.1002/ddr.21679 Abstract In late 2019, a new coronavirus emerged in Wuhan Province, China, causing lung complications similar to those produced by the SARS coronavirus in the 2002-2003 epidemic. This new disease was named COVID-19 and the causative virus SARS-CoV-2. The SARS-CoV-2 [...]
Categories: MATH+
Tags: COVID-19, telmisartan